Back to CVE records
High 7.4HealthcarePublished Jun 24, 2022

CVE-2022-15243.2.5 CLEARTEXT TRANSMISSION OF SENSITIVE INFORMATION CWE-319

Updated under an hour ago ()

Does this affect you?

It affects Illumina NextSeq 550Dx and 7 other products. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.32%, higher than 23% of scored CVEs.

LRM version 2.4 and lower does not implement TLS encryption. A malicious actor can MITM attack sensitive data in-transit, including credentials.

CVSS
7.4 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
Weakness (CWE)
CWE-319
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.32% (percentile 23)
Assigned by
icscert
NVD analysis
Modified
Record last updated
Apr 16, 2025
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
Illumina NextSeq 550Dx
illumina:nextseq_550dx (from the name)
LRM Versions 1.3 to 3.1
CNA record
Illumina MiSeq Dx
illumina:miseq_dx (from the name)
LRM Versions 1.3 to 3.1
CNA record
Illumina NextSeq 500 Instrument
illumina:nextseq_500_instrument (from the name)
LRM Versions 1.3 to 3.1
CNA record
Illumina NextSeq 550 Instrument
illumina:nextseq_550_instrument (from the name)
LRM Versions 1.3 to 3.1
CNA record
Illumina MiSeq Instrument
illumina:miseq_instrument (from the name)
LRM Versions 1.3 to 3.1
CNA record
Illumina iSeq 100 Instrument
illumina:iseq_100_instrument (from the name)
LRM Versions 1.3 to 3.1
CNA record
Illumina MiniSeq Instrument
illumina:miniseq_instrument (from the name)
LRM Versions 1.3 to 3.1
CNA record
illumina local_run_manager
illumina:local_run_manager
from 1.3 through 3.1
NVD

References

  • x-refsource-misc, third-party-advisory, us-government-resource

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.